aVenture is in Alpha: aVenture recently launched early public access to our research product. It's intended to illustrate capabilities and gather feedback from users. While in Alpha, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to temporarily present this information to showcase the product's potential, but you should not yet rely upon it for your investment decisions.
aVenture is in Alpha: aVenture recently launched early public access to our research product. It's intended to illustrate capabilities and gather feedback from users. While in Alpha, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to temporarily present this information to showcase the product's potential, but you should not yet rely upon it for your investment decisions.
© aVenture Investment Company, 2024. All rights reserved.
44 Tehama St, San Francisco, CA 94105
Privacy Policy
aVenture Investment Company ("aVenture") is an independent venture capital research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals.
While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision.
aVenture does not offer investment advisory services and is not registered as an investment adviser. The data provided by aVenture does not constitute recommendations or advice, whether by methodology or a statement written by a staff member of aVenture.
Links to external websites do not imply endorsement or affiliation with aVenture. References or links to providers offering the ability to invest in a primary or secondary transaction in a company are for convenience purposes only. They are not solicitations or offers to buy or sell an investment. Remember that past performance does not guarantee future results, and venture capital and private assets should be a contributory part of a diversified portfolio.
Founded by Prof. Günther Laukien, Bruker BioSpin is a leading global provider of magnetic resonance and preclinical imaging instruments. The company’s core mission is to enable high-value life science research and diagnostics solutions, with a vision to advance scientific understanding and improve human health. Bruker BioSpin offers a comprehensive range of products, including spatial biology and single-cell analysis tools, biopharma and applied solutions, and advanced neuro research technologies. Their market focus spans life sciences, diagnostics, and various applied research fields.
Notable affiliated individuals include the founder, Prof. Günther Laukien, whose legacy continues to influence the company's innovative direction. Bruker BioSpin has achieved significant milestones, such as the development of groundbreaking instruments like the timsTOF Ultra and neofleX™. Their impact is evident in the advancement of neuro research and immuno-oncology, among other areas. The company’s contributions have solidified its reputation as a pivotal player in the scientific community, driving forward both academic and applied research globally.
Operating Status
Active
Ownership Type(s)
Public
Main Product(s)
Imaging
Technology
Biotech
Tags
Biotech
Model Types
Hardware
Revenue Type(s)
Transactional
Customer Type(s)
Enterprise
Geographic Exposure
Global
When was Bruker BioSpin founded?
Bruker BioSpin was founded in 1960.
Where is Bruker BioSpin’s headquarters located?
Bruker BioSpin’s headquarters is located in DE, US.
How many employees does Bruker BioSpin have?
Bruker BioSpin has 7500 employees as of Feb 10, 2024.
How much has Bruker BioSpin raised to-date?
As of July 05, 2023, Bruker BioSpin has raised a total of $22.5M (USD) since Dec 12, 2019.
Add Comparison
Total Raised to Date
$22.5M
USD
Last Update Dec 12, 2019
Total Employees Over Time
7500
As of Feb 2024
Bruker BioSpin Address
Delaware
United States of America
Source(s): This page includes data and analysis provided by the company, OpenAI, and our research analysts